| An Observational Study Called H2H-OSCAR-US to Learn More About How Well Rivaroxaban Works and How Safe it is Compared to Apixaban Under Real World Conditions in People in the US With Cancer Who Have Problems Due to Formation of Blood Clots in the Veins (Venous Thromboembolism) (NCT05461807) | Bayer | 2022-07-14 |
| Exclusion of Venous Thrombo-Embolism With a New Clinical Decision Support (NCT06480994) | Diagnostica Stago R&D | 2022-06-21 |
| THromboprophylaxis In Sickle Cell Disease With Central Venous Catheters (THIS) (NCT05033314) | University Health Network, Toronto | 2022-06-07 |
| NOACs Use in AF or VTE (SUNSHINE Registry) (NCT05378308) | Henan Provincial People's Hospital | 2022-06-06 |
| Anti Xa Monitoring Low Molecular Weight Heparin on Prevention of Venous Thromboembolism (NCT05382481) | Xuanwu Hospital, Beijing | 2022-05-16 |
| Postpartum Heparin Against Venous Thromboembolism: a Pilot Randomized Controlled Trial (NCT05878899) | University Hospital, Geneva | 2022-05-03 |
| Efficacy of ICU-VTE Scale in ICU Patients (NCT05487066) | Lijuan Zhang | 2022-05-01 |
| Cancer Associated Thrombosis : What is the Proportion of Patients Ineligible to a Study as CARAVAGGIO (NCT04846556) | Centre Hospitalier Universitaire de Saint Etienne | 2022-04-01 |
| RIVET - Retrospective Cohort Study on the Risk of Venous Thromboembolism (NCT02828904) | Center for Epidemiology and Health Research, Germany | 2022-03-10 |
| Sonoclot to Evaluate Thrombotic Risk in Proteinuric Pregnancy (NCT05108389) | Nottingham University Hospitals NHS Trust | 2022-03-01 |
| Platelet FcGammaRIIa and Risk of Venous Thromboembolism in Cancer (NCT05240508) | University of Vermont | 2022-01-01 |
| Development and Validation of an Interpretable Machine Learning Model for Predicting Venous Thromboembolism（VTE）in Intensive Care Unit (ICU) Patients (NCT07596264) | Beijing Tsinghua Chang Gung Hospital | 2022-01-01 |
| anti10a Levels in Women Treated With LMWH in the Postpartum Period (NCT02856295) | HaEmek Medical Center, Israel | 2021-11-20 |
| Medication Use Evaluation for Enoxaparin in Hospitalized COVID-19 Patients (NCT05226793) | Methodist Health System | 2021-11-17 |
| Hemostasis and Inflammation in COVID-19 Patients With Venous and Arterial Thrombotic Complications (NCT05143567) | Ryazan State Medical University | 2021-11-01 |
| Use of Tranexamic Acid in Reduction Mammoplasty (NCT04947514) | Montefiore Medical Center | 2021-10-29 |
| Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study (NCT05897697) | Marc Blondon | 2021-09-24 |
| Postoperative Extended Venous Thromboprophylaxis in Inflammatory Bowel Disease (NCT03935451) | McMaster University | 2021-09-01 |
| Treatment Patterns and Bleeding Risk of Anticoagulants in Patients With Venous Thromboembolism in Korea (NCT05022563) | Pfizer | 2021-08-31 |
| Low Molecular Weight hEparin vs. Aspirin Post-partum (NCT05058924) | Mount Sinai Hospital, Canada | 2021-08-29 |
| Impact of COVID-19 Vaccines on Cerebrovascular Health (NCT04992195) | Chinese University of Hong Kong | 2021-07-05 |
| Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study (NCT03988231) | University of Utah | 2021-07-01 |
| The Incidence of Venous Thromboembolism in Atopic Dermatitis (NCT04969653) | Momentum Data | 2021-06-21 |
| Leiden Thrombosis Recurrence Risk Prevention (NCT06087952) | Leiden University Medical Center | 2021-06-18 |
| Prevalence of Gynecological Pathologies and Use of Hormonal Treatments in Women Hospitalized for a Venous Thromboembolic Episode (NCT04920487) | Fondation Hôpital Saint-Joseph | 2021-06-05 |
| OsciPulse Device for the Prevention of VTE (NCT04625673) | University of Pennsylvania | 2021-05-12 |
| Prediction of the COBRRA VTE Anticoagulant Trial in Healthcare Claims Data (NCT05264168) | Brigham and Women's Hospital | 2021-05-03 |
| Changes in Coagulation in Colorectal Cancer Patients Undergoing Surgical Treatment (NCT04744688) | University of Aarhus | 2021-04-06 |
| the Effectiveness of Different Risk Scales In Predicting VTE in Respiratory Inpatients (NCT04963374) | Peking University Third Hospital | 2021-04-01 |
| Multicentric Prospective Validation of a Universal Test to Quantify Apixaban, Rivaroxaban, Danaparoid and Fondaparinux Levels (NCT04539301) | Nantes University Hospital | 2021-04-01 |
| Rivaroxaban in Elderly Chinese Venous Thromboembolism Patients (NCT06194617) | Peking Union Medical College Hospital | 2021-04-01 |
| Clotting Parameters After Medical Abortion (NCT04824118) | NHS Lothian | 2021-03-26 |
| A Performance Evaluation of the LumiraDx Point Of Care D-dimer Assay (NCT04737954) | LumiraDx UK Limited | 2021-03-18 |
| Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty (NCT04295486) | University of Miami | 2021-03-01 |
| Individual Dose Adjustment of Low-molecular-weight-heparin by Thromodynamics Test. (NCT04710732) | Pirogov Russian National Research Medical University | 2021-03-01 |
| Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism (NCT04168203) | Brigham and Women's Hospital | 2021-03-01 |
| Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Major Cancer Surgery (NCT04479579) | McMaster University | 2021-02-22 |
| Statins for Venous Event Reduction in Patients With Venous Thromboembolism (NCT04319627) | Ottawa Hospital Research Institute | 2021-02-10 |
| Clinical Trial of Dimolegin (DD217) in Prevention of Thrombotic Complications in Patients With COVID-19 (NCT05185804) | PharmaDiall Ltd. | 2021-02-08 |
| VTE Prevention Following Total Hip and Knee Arthroplasty (NCT04075240) | Sudeep Shivakumar | 2021-02-04 |
| Venous Thrombo-Embolism Imaging Database (VTE-ID) (NCT06258694) | University Hospital, Brest | 2021-01-14 |
| LMWH Compliance in Pregnancy (NCT05066867) | Cork University Maternity Hospital | 2021-01-01 |
| A Universal Electronic Health Record-based IMPROVE DD VTE Risk Assessment Model for the Prevention of Thromboembolism in Hospitalized Medically Ill Patients (NCT04768036) | Northwell Health | 2020-12-21 |
| Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study) (NCT04257487) | Arianna Anticoagulazione Foundation | 2020-12-21 |
| Examining the Experiences of Children With Blood Disorders (NCT04600609) | University of Texas Southwestern Medical Center | 2020-11-09 |
| Using a Real-Time Risk Prediction Model to Predict Pediatric Venous Thromboembolism (VTE) Events (NCT04574895) | Vanderbilt University Medical Center | 2020-11-02 |
| Venous Thromboembolism Prophylaxis After Gynecological Pelvic Cancer Surgery With Rivaroxaban vs Enoxaparin (NCT04999176) | André Luiz Malavasi Longo de Oliveira | 2020-10-22 |
| Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy: The MICHELLE Trial (NCT04662684) | Science Valley Research Institute | 2020-10-16 |
| Pilot PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity (NCT04153760) | University of Calgary | 2020-10-07 |
| Replication of the EINSTEIN-DVT Anticoagulant Trial in Healthcare Claims Data (NCT04736420) | Brigham and Women's Hospital | 2020-09-22 |
| Replication of the RECOVER-II Anticoagulant Trial in Healthcare Claims Data (NCT04735523) | Brigham and Women's Hospital | 2020-09-22 |
| Replication of the AMPLIFY Anticoagulant Trial in Healthcare Claims Data (NCT04736719) | Brigham and Women's Hospital | 2020-09-22 |
| Effectiveness of Interventions for Hospital Medical Thromboprophylaxis: a Bicentric Swiss Quality-improvement Study (NCT05306821) | Marc Blondon | 2020-09-01 |
| Apixaban vs Enoxaparin Following Microsurgical Breast Reconstruction-An RCT (NCT04504318) | Stanford University | 2020-08-12 |
| Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy (NCT04352439) | Duke University | 2020-08-08 |
| Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial (NCT04409834) | The TIMI Study Group | 2020-08-05 |
| Study to Compare the Effectiveness of Rivaroxaban (Xarelto) Versus Low-molecular-weight Heparin (LMWH) and Phenprocoumon for the Treatment and Secondary Prevention of Venous Thromboembolism in Routine Clinical Practice in Germany (NCT04444804) | Bayer | 2020-07-31 |
| Clonal Hematopoiesis of Indeterminate Potential in Venous Thromboembolism (NCT04477564) | Centre Hospitalier Universitaire de Nīmes | 2020-07-03 |
| Risk Stratification for Venous Thromboembolism in Hospitalized Medical Patients (NCT04439383) | Insel Gruppe AG, University Hospital Bern | 2020-06-22 |
| Thromboembolic Risk Stratification by TRiP(Cast) Score to Guide Physicians in Preventive Treatment Prescriptions for Patients With Lower Limb Trauma Requiring Brace or castING. (NCT04064489) | University Hospital, Angers | 2020-06-16 |
| Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 Pandemic (NCT04400877) | University Hospital, Linkoeping | 2020-06-08 |
| Management of Recurrent Venous Thromboembolism During Anticoagulant Treatment in Cancer Patients - a Prospective Cohort Study (NCT05229471) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2020-06-02 |
| Effect of the Genotype on Postoperative DVT (NCT04940377) | Rigshospitalet, Denmark | 2020-06-01 |
| Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism (NCT04263038) | Drahomir Aujesky | 2020-05-15 |
| Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters (NCT04066764) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2020-05-08 |
| Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19 (NCT04374617) | Hospital Universitari Vall d'Hebron Research Institute | 2020-04-01 |
| Cardiovascular Complications and COVID-19 (CovCardioVasc-Study) (NCT04335162) | Centre Hospitalier Universitaire de Nice | 2020-02-28 |
| The Portuguese Survey on Anticoagulated Patients Register (START-Portugal-Register) (NCT03977363) | CHAD | 2020-01-27 |
| Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs Rivaroxaban (NCT04169269) | Florida Orthopaedic Institute | 2020-01-13 |
| A Study on the Impact of Rabeprazole-induced Elevated Stomach pH on APO-Dabigatran Exposure in Healthy Volunteers (NCT04157881) | Population Health Research Institute | 2020-01-03 |
| COVID-19 and Venous Thromboembolism Risk (NCT04569344) | University of California, San Francisco | 2020-01-01 |
| A Prospective Study in Chinese Patients With Lower Extremity Ankle Fracture of Oral Anticoagulants to Prevent Venous Thromboembolism (VTE) (NCT04128254) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2020-01-01 |
| Impact of Early Debriefing and Enhanced Educative Components on Direct Oral Anticoagulant Adherence After Venous Thromboembolism. (NCT04141254) | University Hospital, Brest | 2019-12-27 |
| LEAVE Safe With DOACs (NCT04068727) | University of Massachusetts, Worcester | 2019-12-02 |
| The Affect Of An Anti-Embolism Stocking Protocol (NCT06616376) | Cukurova University | 2019-10-16 |
| Thrombus Elastography in Venous Thrombo-Embolism. (NCT04130048) | University Hospital, Brest | 2019-10-10 |
| Role of Statin in Venous Dysfunction in Patients With Venous Thromboembolism Event (NCT03988101) | Yonsei University | 2019-09-19 |
| Perioperative Anticoagulant Use for Surgery Evaluation Emergency Registry (NCT04195113) | McMaster University | 2019-08-07 |
| Improving Safety of Diagnosis and Therapy in the Inpatient Setting (NCT04393909) | Brigham and Women's Hospital | 2019-07-01 |
| A Study to Evaluate Dimolegin in Prevention of Thromboembolic Complications During Knee Replacement (NCT05189002) | PharmaDiall Ltd. | 2019-05-31 |
| PET Fibrin Imaging of DVT and PE (NCT04022915) | Peter Caravan | 2019-05-13 |
| Prophylaxis With Apixaban in Transplant Eligible Patients With Multiple Myeloma Receiving Induction Therapy With IMiDs (NCT04106700) | Instituto de Investigacion Sanitaria La Fe | 2019-04-12 |
| Study to Assess the Safety and Efficacy of SelK2 to Prevent Blood Clots in Patients Undergoing Total Knee Replacement (NCT03812328) | Tetherex Pharmaceuticals Corporation | 2019-02-20 |
| The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study (NCT03835780) | Momentum Data | 2019-02-01 |
| Computerized Decision Support for Prevention of VTE in Hospitalized Medical Patients Across the Continuum of Care (DC-eALERT) (NCT03728166) | Brigham and Women's Hospital | 2019-02-01 |
| A Two-Part Study to Assess the Safety, Tolerability, PK and PD of ONO-7684 in Healthy Adult Volunteers (NCT03919890) | Ono Pharmaceutical Co., Ltd. | 2019-01-17 |
| Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors (NCT06950697) | Beijing Chao Yang Hospital | 2019-01-01 |
| Development and Validation of the Patient-completed Caprini Risk Score (NCT04663477) | China-Japan Friendship Hospital | 2019-01-01 |
| Evaluating the Risk of Postoperative Venous Thromboembolism in Cervical Cancer Patients (NCT06556953) | Haike Lei | 2019-01-01 |
| Longitudinal Hemostatic Profile After Stopping Estroprogestative Contraceptives (NCT03949985) | University Hospital, Geneva | 2018-10-08 |
| Safety and Efficacy Study of Fitaya Vena Cava Filter (NCT03691753) | Lifetech Scientific (Shenzhen) Co., Ltd. | 2018-09-29 |
| Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE) (NCT03090880) | Assistance Publique - Hôpitaux de Paris | 2018-09-14 |
| Risk Factors and Outcomes of Acute Venous Thromboembolism in Cirrhotic (NCT03580577) | Assiut University | 2018-09-01 |
| Risk, Predictors, Impact and Outcome of Anticoagulation-associated Abnormal Menstrual Bleeding (NCT04748393) | Leiden University Medical Center | 2018-09-01 |
| Swedish Multicenter Trial of Outpatient Prevention of Leg Clots (NCT03259204) | Karolinska University Hospital | 2018-09-01 |
| Apixaban for Extended Anticoagulation (APIDULCIS) (NCT03678506) | Arianna Anticoagulazione Foundation | 2018-08-16 |
| Comparison of Oral Anticoagulants for Extended VEnous Thromboembolism (NCT03196349) | Duke University | 2018-08-01 |
| Risk Factors and a nOmogram of Venous thromboEmbolism in Patients After liveR Transplantation(ROVER Study) (NCT05209048) | Beijing Tsinghua Chang Gung Hospital | 2018-08-01 |
| Venous Thromboembolism in Advanced Lung Cancer (NCT03581708) | Guangdong Provincial People's Hospital | 2018-07-01 |
| Detecting Circulating Emboli in Patients with Acute Venous Thromboembolism (NCT02735759) | University of Arkansas | 2018-07-01 |